Gts Securities LLC Argenx Se Transaction History
Gts Securities LLC
- $2.31 Trillion
- Q1 2025
A detailed history of Gts Securities LLC transactions in Argenx Se stock. As of the latest transaction made, Gts Securities LLC holds 629 shares of ARGX stock, worth $353,340. This represents 0.02% of its overall portfolio holdings.
Number of Shares
629
Previous 501
25.55%
Holding current value
$353,340
Previous $308 Million
20.83%
% of portfolio
0.02%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding ARGX
# of Institutions
494Shares Held
28.4MCall Options Held
330KPut Options Held
286K-
Price T Rowe Associates Inc Baltimore, MD5.38MShares$3.02 Billion0.39% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI2.79MShares$1.56 Billion2.84% of portfolio
-
Janus Henderson Group PLC London, X02.14MShares$1.2 Billion0.73% of portfolio
-
Capital World Investors Los Angeles, CA1.94MShares$1.09 Billion0.19% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.24MShares$694 Million11.83% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $31.1B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...